Approaches to Disease Burden Measurement: Disability-Adjusted Life Years (DALYs) Globally and in Poland, and National Income Lost Due to Disease in Poland, 1990-2015

• Autorzy: Katarzyna Kissimova-Skarbek
• Języki publikacji: EN

Abstrakty

EN

The purpose of this study was to identify the main health problems in Poland against global health problems using the latest Global Burden of Disease (GBD) study results. The burden of disease is assessed here in terms of: (i) time lost due to premature deaths and morbidity (expressed in Disability-Adjusted Life Years - DALYs measure) and (ii) national income lost due to disease in Poland. The study presents the estimates of total DALYs, Years of Life Lost (YLL) caused by deaths, Years Lived with Disabilities (YLD), both in total (due to all causes) and attributable to chronic non-communicable diseases (NCDs), in 2015. The economic value of time lost due to deaths and disability in Poland is measured using the method employed by the WHO Commission for Macroeconomics and Health, which makes the assumption that each DALY can be valued at between one and three annual GDPs per-capita for the country under study. In 2015 over 2.46 bln DALYs globally were lost due to all causes, of which 66.7% were due to NCDs and 18.2% were due to communicable diseases. Poland experienced over 11.3 mln DALYs in the year 2015, 81.9%of which were due to NCDs and 3.4% of which were due to communicable diseases. 68% of total DALYs globally and 41% in Poland were years of life lost due to deaths. 84% of the total years of life lost due to death in 2015 globally (69% in Poland) occurred under the age of 70 and are considered avoidable. Total income lost in Poland due to deaths in 2015 amounted to up to I$527 bln. (original abstract)

Słowa kluczowe

EN

Illness; Life expectancy; Chronic diseases; National income

PL

Choroby; Długość życia; Choroby przewlekłe; Dochód narodowy

• Czasopismo: Zdrowie Publiczne i Zarządzanie
• Rocznik: 2016
• Tom: 14
• Numer: nr 3
• Strony: 175--193

Twórcy

autor

Katarzyna Kissimova-Skarbek

• Jagiellonian University

Bibliografia

• Murray C.J.L., Lopez A.D., Evidence-based health policy - lessons from the Global Burden of Disease Study, "Science" 1996, 274 (5288): 740-743.
• Kissimova-Skarbek K., Koszty obciążenia chorobami, in: Golinowska S. (ed.), Od ekonomii do ekonomiki zdrowia. Podręcznik ekonomiki zdrowia, PWN, Warszawa 2015: 354-391.
• Murray C.J.L., Lopez A.D., The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Global Burden of Disease and Injury Series, Volume I, Harvard University Press, Cambridge 1996.
• Dempsey M., Decline in tuberculosis - the death rate fails to tell the entire story, "American Review of Tuberculosis" 1947, 56: 157-164.
• Kocot E., Wskaźniki ekonomiczne, społeczne i zdrowotne, in: Golinowska S. (ed.), Od ekonomii do ekonomiki zdrowia. Podręcznik ekonomiki zdrowia, PWN, Warszawa 2015: 145-170.
• Kozierkiewicz A., Megas B., Natkaniec M., Topór-Mądry R., Kissimova-Skarbek K., Śliwczyński A., Gajda K., Years of life lost due to deaths in Poland measured with Potential Years of Life Lost (PYLL) and Period Expected Years of Life Lost (PEYLL) indicators in years 2000-2014, "Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarządzanie" 2016; 14 (3): 165-174.
• World Bank, World Development Report 1993. Investing in Health, Oxford University Press, New York 1993.
• Murray C.J.L., Lopez A.D., Jamison D.T., The Global Burden of Disease in 1990: Summary Results, Sensitivity Analysis, and Future Directions, "Bulletin of the World Health Organization" 1994; 72 (3): 495-509.
• Murray C.J.L., Lopez A.D., Global comparative assessments in the health sector, World Health Organization, Geneva 1994.
• Murray C.J.L., Lopez A.D., Global Health Statistics. A Compendium of Incidence, Prevalence, and Mortality Estimates for Over 200 Conditions. Global Burden of Disease and Injury Series, Volume II. Harvard University Press, Cambridge 1996.
• The Global Burden of Disease Study 2010, "Lancet" 2012; 380 (9859): 2053-2260.
• GBD 2015 Mortality and Causes of Death Collaborators, Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015, "Lancet" 2016; 388: 1459-544.
• GBD 2015 Disease and Injury Incidence and Prevalence Collaborators, Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015, "Lancet" 2016; 388: 1545-602.
• Kissimova-Skarbek K., Pach D., Płaczkiewicz E., Szurkowska M., Szybiński Z., Ocena ekonomicznego obciążenia cukrzycą społeczeństwa Polski, "Polskie Archiwum Medycyny Wewnętrznej" 2001, Tom 106, Nr 3 (9), Urban & Partner Wydawnictwo Medyczne, Wrocław 2001: 867-875.
• Kissimova-Skarbek K., Ekonomika cukrzycy - wybrane zagadnienia metodologiczne, "Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarzadzanie" 2007; V (1-2): 46-64.
• Bloom D.E., Cafiero E.T., Jané-Llopis E., Abrahams-Gessel S., Bloom L.R., Fathima S., Feigl A.B., Gaziano T., Mowafi M., Pandya A., Prettner K., Rosenberg L., Seligman B., Stein A., Weinstein C., The Global Economic Burden of Non-communicable Diseases, World Economic Forum, Geneva 2011.
• Abegunde, D., Stanciole, A., An estimation of the economic impact of chronic noncommunicable diseases in selected countries, WHO Working Paper, World Health Organization Department of Chronic Diseases and Health Promotion, Geneva 2006.
• Aldy E.J., Viscusi W.K., Age Differences in the Value of Statistical Life: Revealed Preference Evidence, RFF Discussion Paper 07-05, April 2007, http://www.rff.org/rff/Documents/RFF-DP-07-05.pdf; accessed: 7.05.2015.
• Fein R., Economics of Public Health, Basic Books, New York 1958.
• Mushkin S.J., Collins F., Economic costs of disease and injury, "Public Health Reports" 1959; 74: 795-809.
• Weisbord B.A., Economics of Public Health, University of Pennsylvania Press, Philadelphia 1961.
• Rice D.P., Estimating the Cost of Illness, "Health Economics Series" 1966; 6, US Government Printing Office, Washington DC.
• World Health Organisation, The World Health Report 2002 - Reducing risks, promoting healthy life, World Health Organization, Geneva 2002.
• Rice P.D., Hodgson T.A., Kopstein A.N., The economic costs of illness: A replication and update, "Health Care Financ. Rev." 1985 Fall; 7 (1): 61-80.
• Rice D.P., Cost-of-illness studies: fact or fiction? "The Lancet" 1994; 344: 1519-1521.
• Drummond M., McGuire A. (eds), Economic evaluation in health care. Merging theory with practice, Oxford University Press, New York 2001: 68-93.
• Koopmanschap M.A., Rutten F.F.H., van Ineveld B.M., van Roijen L., The friction cost method of measuring the indirect costs of disease, "Journal of Health Economics" 1995; 14: 171-189.
• Koopmanschap M.A., Rutten F.F., A practical guide for calculating indirect costs of disease, "Pharmacoeconomics" 1996; 10 (5): 460-466.
• Krol M., Brouwer W., How to Estimate Productivity Costs in Economic Evaluations, "PharmacoEconomics" 2014; 32 (4): 335-344.
• Jönsson B., The economic impact of diabetes, "Diabetes Care" 1998, 21 (Suppl. 3): C7-C10.
• Cooper B.S., Rice D.P., The economic cost of illness revised, "Soc. Sec. Bull." 1976; 39: 21-36.
• Gold M.R., Siegel J.E., Russell L.B., Weinstein M.C., Cost-effectiveness in health and medicine, Oxford University Press, New York 1996.
• Hermanowski T., Szacowanie kosztów społecznych choroby i wpływu stanu zdrowia na aktywność zawodową i wydajność pracy, Wolters Kluwer Polska, Warszawa 2013.
• World Health Organization, Macroeconomics and health: Investing in health for economic development. Report of the Commission on Macroeconomics and Health, Geneva 2001.
• World Health Organization, Preventing chronic disease: a vital investment. A WHO Report, Geneva 2005, http://apps.who.int/iris/bitstream/10665/43314/1/9241563001_eng.pdf; accessed: 27.04.2011.
• International Diabetes Federation, IDF Diabetes Atlas seventh edition, Brussels 2015, www.diabetesatlas.org; accessed: 11.10.2016.
• Global Burden of Disease Study 2015. (GBD 2015) Results. Seattle United States: Institute for Health Metrics and Evaluation (IHME) 2016, https://http://vizhub.healthdata.org/gbd-compare/; accessed: 22.10.2016.
• Institute for Health Metrics and Evaluation (IHME), Rethinking Development and Health: Findings from the Global Burden of Disease Study. IHME, Seattle, WA 2016.
• Institute for Health Metrics and Evaluation, Global Burden of Disease Study 2010. GBD Compare. Results by cause, Seattle, United States 2015.
• World Bank, World Development Indicators, GDP deflators, http://data.worldbank.org/indicator/NY.GDP.DEFL.ZS; accessed: 8.10.2016.
• World Bank, World Development Indicators, PPP conversion factor, GDP (Local Currency Unit per international $), International Comparison Program database, http://data. worldbank.org/indicator/PA.NUS.PPP; accessed: 8.10.2016.
• Oxford Health Alliance working group, Economic consequences of chronic diseases and the economic rationale for public and private intervention, Draft for circulation to participants of OHA 2005 conference, 21 October 2005.
• World Bank, World Development Indicators, GDP per capita PPP (current international $), http://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD; accessed: 8.10.2016.

Identyfikatory

DOI

10.4467/20842627OZ.16.021.5890